Eli Lilly & Co
A pharmaceutical company whose medicines treat diabetes and obesity (Mounjaro, Zepbound, Trulicity, Jardiance), cancer (Verzenio, Cyramza), immunology conditions, and neurological diseases like migraine and Alzheimer's. Founded in 1876 in Indianapolis by Colonel Eli Lilly, a Civil War veteran and chemist, the firm started as a wholesale drug maker. Its founder opened the lab partly to fight the "snake oil" patent medicines of his day, vowing to sell only high-quality remedies recommended by physicians.
Sold 3.86M
Granted 70.8K
Granted 28.2K
Granted 318.61
Granted 8.7K
Granted 341.65
Granted 15.0K
Granted 8.0K
Granted 9.0K
Granted 7.6K · Sold 2.5K
Granted 8.4K
Granted 215.33
Granted 215.33
Granted 376.23
Granted 1.7K
Granted 6.4K
Granted 866.28
Granted 215.33
Granted 767.78 · Sold 1.0K
Granted 1.6K
Granted 215.33
Granted 266.97
Granted 259.89
Granted 233.27
| Insider | Stake change | Holds now | Granted / vested | Bought | Sold |
|---|---|---|---|---|---|
| Lilly Endowment IncFormer 10% Shareholder · 370 transactions | -4.1% | 91.88M | — | — | 3.86M |
| Ricks David APresident, Chair, and CEO, Director · 4 transactions | — | 708.8K | 70.8K | — | — |
| Skovronsky DanielEVP, CS&PO & Pres. LRL · 4 transactions | +10.5% | 235.7K | 28.2K | — | — |
| Fyrwald J ErikDirector · 11 transactions | +1.1% | 75.4K | 318.61 | — | — |
| Jonsson PatrikEVP & President, LLY Int'l · 3 transactions | +13% | 61.3K | 8.7K | — | — |
| Alvarez RalphDirector · 11 transactions | +1.3% | 56.5K | 341.65 | — | — |
| Hakim AnatEVP, GC & Secretary · 3 transactions | +27.6% | 55.6K | 15.0K | — | — |
| Hernandez EdgardoEVP & Pres., Mfg. Operations · 4 transactions | +12.2% | 47.0K | 8.0K | — | — |
| Van Naarden JacobEVP,Pres LLY Oncology&HdCorpBD · 3 transactions | — | 40.6K | 9.0K | — | — |
| Yuffa IlyaEVP&Pres, LLY USA&Global Capab · 4 transactions | +13.5% | 29.8K | 7.6K | — | 2.5K |
| Rau DiogoEVP & CIDO · 3 transactions | +33.9% | 26.4K | 8.4K | — | — |
| Baicker KatherineDirector · 1 transaction | +1.7% | 23.5K | 215.33 | — | — |
| Kaelin William G JrDirector · 1 transaction | +1.7% | 21.8K | 215.33 | — | — |
| Luciano Juan RDirector · 11 transactions | +3% | 16.9K | 376.23 | — | — |
| Montarce LucasEVP & CFO · 3 transactions | +10.7% | 16.3K | 1.7K | — | — |
| Dozier EricEVP, Chief People Officer · 4 transactions | +45.9% | 14.8K | 6.4K | — | — |
| Custer Kenneth L.EVP & President, Card Met Hlth · 3 transactions | +9.5% | 10.2K | 866.28 | — | — |
| Jackson JamereDirector · 1 transaction | +2.5% | 9.6K | 215.33 | — | — |
| Zakrowski Donald ASVP, Finance, & CAO · 4 transactions | -5.6% | 5.3K | 767.78 | — | 1.0K |
| Brown Adrienne SEVP, President LLY Imm · 3 transactions | — | 5.1K | 1.6K | — | — |
| Johnson Kimberly HDirector · 1 transaction | +7.7% | 3.3K | 215.33 | — | — |
| Sulzberger GabrielleDirector · 11 transactions | +10.5% | 3.0K | 266.97 | — | — |
| Hedley Mary LynneDirector · 5 transactions | +12.8% | 2.4K | 259.89 | — | — |
| Moeller Jon RDirector · 1 transaction | +328.5% | 304.27 | 233.27 | — | — |
Select a row to see that insider’s individual transactions. Sum of the holdings confirmed in the 12 months before this insider's last filing. A Form 4 reports a holding per line — held directly, or through a named trust, partnership or foundation, and in each share class separately — never a person’s total. Lines not restated in that time are left out and shown apart: an active filer restates what they still hold, so a line they did not restate is more often an entity since renamed, whose shares a successor line reports too. An amber marker means some were left out.
Net open-market activity over the last year: -3.86M shares. Grants, option exercises and tax withholding are excluded — they are compensation mechanics, not decisions to buy or sell.